In this study, we present the first APOL1-mediated kidney disease (AMKD) model incorporating patient-derived induced pluripotent stem cells (iPSCs) with both homozygous G1G1 and G2G2 risk genotypes. The gene discussed is APOL1; the disease is kidney disorder.